Table 6:
Intrafluid biofilm heterogeneity testing after treatment with tobramycin at concentration levels 25, 50, 100, 200, 400 μg ml−1. 100 independent paths of length 1800 were randomly selected for each concentration level.
Tobramycin (μg ml−1) | p-value |
---|---|
25 | < 10−16 |
50 | < 10−16 |
100 | < 10−16 |
200 | < 10−16 |
400 | < 10−16 |